Table 4. Expression of TAZ in relation to distant recurrence probability in rectal cancer patients with preoperative RT.

Characteristics	Univariate	Multivariate
	p-value	HR (95% CI)	p-value
TAZ expression
Weak vs. Strong	0.012	6.160 (1.063–35.7036)	0.043
Gender
Male vs. Female	0.157	0.228 (0.022–2.326)	0.212
Age (year)
≤67 vs.>67	0.602	0.945 (0.195–4.584)	0.944
Stage
I vs. II+IIIA+IIIB	0.010	8.6238 (0.891–83.5035)	0.063
Differentiation
Well+Moderate vs. Poor	0.733	1.561 (0.284–8.582)	0.609

HR, hazard ratio; 95%CI, 95% confidence interval.